Skip to main content
IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.040
-0.040 (-3.70%)
Apr 28, 2026, 4:00 PM EDT - Market closed

IRIDEX Revenue

In the fiscal year ending January 3, 2026, IRIDEX had annual revenue of $52.68M with 8.23% growth. IRIDEX had revenue of $14.72M in the quarter ending January 3, 2026, with 15.97% growth.

Revenue (ttm)
$52.68M
Revenue Growth
+8.23%
P/S Ratio
0.34
Revenue / Employee
$566,398
Employees
93
Market Cap
18.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 3, 202652.68M4.01M8.23%
Dec 28, 202448.67M-3.20M-6.17%
Dec 30, 202351.87M-5.10M-8.96%
Dec 31, 202256.97M3.07M5.69%
Jan 1, 202253.90M17.56M48.30%
Jan 2, 2021 Pro Pro Pro
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TELA Bio 80.28M
Trinity Biotech 48.57M
Myomo 40.93M
Lifeward 22.03M
Vivos Therapeutics 17.44M
Pulsenmore 12.55M
IceCure Medical 3.38M
VolitionRx 1.73M
Revenue Rankings

IRIX News

More News